Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Sullivan

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Medicine|May 1, 2004
Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and JapanJun-Ichi Nishimura, Yuzuru Kanakura, Russell E Ware, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2016
Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple MyelomaDharshan Sivaraj, Michael M Green, Zhiguo Li, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trialOana I Craciunescu, Beverly A Steffey, Chris R Kelsey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2010
Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United StatesChitra Hosing, Richard Nash, Peter McSweeney, et al.
The Journal of Investigative Dermatology|September 20, 2020
Quantifying Skin Stiffness in Graft-Versus-Host Disease, Morphea, and Systemic Sclerosis Using Acoustic Radiation Force Impulse Imaging and Shear Wave ElastographyAdela R Cardones, Russell P Hall, Keith M Sullivan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2018
Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow TransplantationKeith M Sullivan, Navneet S Majhail, Christopher Bredeson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2010
Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioningJunya Kanda, David A Rizzieri, Cristina Gasparetto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2024
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular SignaturesNancy Wareing, Xuan Wang, Lynette Keyes-Elstein, et al.
Annals of the Rheumatic Diseases|September 16, 2020
Machine learning predicts stem cell transplant response in severe sclerodermaJennifer M Franks, Viktor Martyanov, Yue Wang, et al.
Cancer Investigation|December 21, 2010
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donorsDavid A Rizzieri, Christopher Crout, Robert Storms, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Medicine|May 1, 2004
Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and JapanJun-Ichi Nishimura, Yuzuru Kanakura, Russell E Ware, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2016
Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple MyelomaDharshan Sivaraj, Michael M Green, Zhiguo Li, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trialOana I Craciunescu, Beverly A Steffey, Chris R Kelsey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2010
Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United StatesChitra Hosing, Richard Nash, Peter McSweeney, et al.
The Journal of Investigative Dermatology|September 20, 2020
Quantifying Skin Stiffness in Graft-Versus-Host Disease, Morphea, and Systemic Sclerosis Using Acoustic Radiation Force Impulse Imaging and Shear Wave ElastographyAdela R Cardones, Russell P Hall, Keith M Sullivan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2018
Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow TransplantationKeith M Sullivan, Navneet S Majhail, Christopher Bredeson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2010
Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioningJunya Kanda, David A Rizzieri, Cristina Gasparetto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2024
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular SignaturesNancy Wareing, Xuan Wang, Lynette Keyes-Elstein, et al.
Annals of the Rheumatic Diseases|September 16, 2020
Machine learning predicts stem cell transplant response in severe sclerodermaJennifer M Franks, Viktor Martyanov, Yue Wang, et al.
Cancer Investigation|December 21, 2010
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donorsDavid A Rizzieri, Christopher Crout, Robert Storms, et al.
Pageof 10